Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

Journal of Experimental Medicine

Volumn 190, Issue 2, 1999, Pages 205-215

  Wang, Zhigang ^a   Marincola, Francesco M ^b,c   Rivoltini, Licia ^d   Parmiani, Giorgio ^d   Ferrone, Soldano ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Histocompatibility leukocyte antigen class I; Melanoma; Splicing defect; Truncated heavy chain

Indexed keywords

HLA A2 ANTIGEN;

ALLELE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EXON; GENE LOSS; GENE MUTATION; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; HUMAN CELL; INTRON; MELANOMA CELL; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSLATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE EXPRESSION; GENES, MHC CLASS I; HLA-A2 ANTIGEN; HUMANS; IMMUNOTHERAPY; INTRONS; MELANOMA; MOLECULAR SEQUENCE DATA; MUTATION; RNA PRECURSORS; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033584229     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.2.205     Document Type: Article

References (57)

1. Ferrone, S., and F.M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16: 487-494.
2. Versteeg, R., I.A. Noordermeer, M. Kruse-Wolters, D.J. Ruiter, and P.I. Schrier. 1988. c-myc down-regulates class I HLA expression in human melanomas. EMBO (Eur. Mol. Biol. Organ.) J. 7:1023-1029.
3. Natali, P.G., M.R. Nicotra, A. Bilgotti, I. Venturo, L. Marcenaro, P. Giacomini, and C. Russo. 1989. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA. 86:6719-6723.
4. Kageshita, T., Z. Wang, L. Calorini, A. Yoshii, T. Kimura, T. Ono, S. Gattoni-Celli, and S. Ferrone. 1993. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res. 53:3349-3354.
5. Marincola, F.M., P. Shamamian, R.B. Alexander, J.R. Gnarra, R.L. Turetskaya, S.A. Nedospasov, B. Simonis, J.K. Taubenberger, J. Yannelli, A. Mixon, et al. 1994. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol. 153:1225-1237.
6. Wang, Z., L. Margulies, D.J. Hicklin, and S. Ferrone. 1996. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression. Tissue Antigens. 47:382-390.
7. van Duinen, S.G., D.J. Ruiter, E.B. Broecker, E.A. van der Velde, C. Sorg, K. Welvaart, and S. Ferrone. 1988. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res. 48: 1019-1025.
8. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Anna. Rev. Immunol. 12:337-365.
9. 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst. 88:100-108.
10. 2-microglobulin gene expression. J. Clin. Invest. 87:284-292.
11. 2-microglobulin messenger RNA. J. Clin. Invest. 91: 684-692.
12. 2-microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J. Clin. Invest. 101:2720-2729.
13. 2-microglobulin gene. J. Clin. Invest. 88:282-289.
14. Wolfel, T., E. Klehmann, C. Muller, K.-H. Schutt, K.-H. Meyer-sum-Buschenfelde, and A. Knuth. 1989. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med. 170:797-810.
15. Wang, Z., B. Seliger, N. Mike, F. Momburg, A. Knuth, and S. Ferrone. 1998. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. Cancer Res. 58:2149-2157.
16. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340-347.
17. Rivoltini, L., K.C. Baracchini, V. Viggiano, Y. Kawakami, A. Smith, A. Mixon, N.P. Restifo, S.L. Topalian, T.B. Simonis, S.A. Rosenberg, and F.M. Marincola. 1995. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res. 55:3149-3157.
18. Anichini, A., R. Mortarini, C. Maccalli, P. Squarcina, K. Fleischhauer, L. Mascheroni, and G. Parmiani. 1996. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J. Immunol. 156:208-217.
19. Kim, C.J., D.R. Parkinson, and F. Marincola. 1998. Immunodominance across HLA polymorphism: implications for cancer immunotherapy. J. Immunother. 21:1-16.
20. Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
21. Nestle, F.O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328-332.
22. Barnstable, C.J., W.F. Bodmer, G. Brown, G. Galfre, C. Milstein, A.F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell. 14:9-20.
23. 3 domain. J. Immunol. 148:3202-3209.
24. Russo, C., A.-K. Ng, M.A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics. 18:23-35.
25. Tsujisaki, M., K. Sakaguchi, M. Igarashi, P. Richiardi, F. Perosa, and S. Ferrone. 1988. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS-1. Transplantation. 45:632-639.
26. McMichael, A.J., P. Parham, N. Rust, and F. Brodsky. 1980. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum. Immunol. 1:121-129.
27. Stam, N.J., T.M. Vroom, P.J. Peters, E.B. Pastoors, and H.L. Ploegh. 1990. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2:113-125.
28. Nakamuro, K., N. Tanigaki, and D. Pressman. 1975. Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000-Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology. 29:1119-1132.
29. bm6. Proc. Natl. Acad. Sci. USA. 83:3371-3375.
30. Vega, M.A., and J.L. Strominger. 1989. Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. USA. 86:2688-2692.
31. Yang, S.Y. 1989. A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis. In Immunobiology of HLA. Vol. 1. B. Dupont, editor. Springer-Verlag Inc., New York. 332-335.
32. Bumette, W.N. 1981. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195-203.
33. Loh, E.Y., J.F. Elliott, S. Cwirla, L.L. Lanier, and M.M. Davis. 1989. Polymerase chain reaction with single-sided specificity: analysis of T cell receptor δ chain. Science. 243: 217-220.
34. Kawasaki, E.S. 1990. Sample preparation from blood, cells and other fluids. In PCR Protocols: A Guide to Methods and Applications. MA. Innis, D.H. Gelfand, J.J. Sninsky, and T.J. White, editors. Academic Press, Inc., San Diego. 146-158.
35. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467.
36. Sernee, M.F., H.L. Ploegh, and D.J. Schust. 1998. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 35:177-188.
37. Mount, S.M. 1982. A catalogue of splice junction sequences. Nucleic Acids Res. 10:459-472.
38. Wassarman, D.A., and J.A. Steitz. 1992. Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing. Science. 257:1918-1925.
39. Montell, C., E.F. Fisher, M.H. Caruthers, and A.J. Berk. 1982. Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site. Nature. 295: 380-384.
40. Aebi, M., H. Hornig, and C. Weissmann. 1987. 5′ cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5′ splice region, not by the conserved 5′ GU. Cell. 50:237-246.
41. Kontusaari, S., G. Tromp, H. Kuivaniemi, R.L. Ladda, and D.J. Prockop. 1990. Inheritance of an RNA splicing mutation (G+1 IVS20) in the type III procollagen gene (COL3A1) in a family having aortic aneurysms and easy bruisability: phenotype overlap between familial arterial aneurysms and Ehlers-Danlos syndrome type IV. Am. J. Hum. Genet. 47:112-120.
42. Ohno, K., and K. Suzuki. 1988. Multiple abnormal β-hexosaminidase α chain mRNAs in a compound-heterozygous Ashkenazi Jewish patient with Tay-Sachs disease. J. Biol. Chem. 263:18563-18567.
43. Nakai, K., and H. Sakamoto. 1994. Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene. 141:171-177.
44. Berget, S.M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411-2414.
45. Talerico, M., and S.M. Berget. 1994. Intron definition in splicing of small Drosaphila introns. Mol. Cell. Biol. 14:3434-3445.
46. Krangel, M.S. 1986. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J. Exp. Med. 163: 1173-1190.
47. Ishitani, A., and D.E. Geraghty. 1992. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA. 89:3947-3951.
48. Browning, M.J., P. Krausa, A. Rowan, D.C. Bicknell, J.G. Bodmer, and W.F. Bodmer. 1993. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. Natl. Acad. Sci. USA. 90:2842-2845.
49. Imreh, M.P., Q.-J. Zhang, P.O. de Campos-Lima, S. Imreh, P. Krausa, M. Browning, G. Klein, and M.G. Masucci. 1995. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma. Int. J. Cancer. 62:90-96.
50. Browning, M.J., P. Krausa, A. Rowan, A.B. Hill, D.C. Bicknell, J.G. Bodmer, and W.F. Bodmer. 1993. Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. J. Immunother. 14:163-168.
51. Koopman, L.A., A. Mulder, W.E. Corver, J.D.H. Anholts, M.J. Giphart, F.H.J. Claas, and G.J. Fleuren. 1998. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens. 51:623-636.
52. Hicklin, D.J., F.M. Marincola, and S. Ferrone. 1999. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol. Med. Today. 5:178-186.
53. + T cells to an antigen that no longer serves as a target. J. Exp. Med. 178:933-940.
54. van Waes, C., P.A. Monach, R.D. Urban, R.D. Wortzel, and H. Schreiber. 1996. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with clone cytolytic T cells in vitro. Tissue Antigens. 47:399-407.
55. Fernandez-Vina, M.A., M. Falco, Y. Sun, and P. Stastny. 1992. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of-A28. Hum. Immunol. 33:163-173.
56. Oh, S.-H., K. Fleischhauer, and S.Y. Yang. 1993. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens. 41:135-142.
57. Ennis, P.D., J. Zemmour, R.D. Salter, and P. Parham. 1990. Rapid cloning of HLA-A, B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc. Natl. Acad. Sci. USA. 87:2833-2837.